Narrow Results Clear All
- Culture of Safety 1
- Education and Training 5
- Error Reporting and Analysis 2
- Human Factors Engineering 5
- Legal and Policy Approaches 2
- Quality Improvement Strategies 2
- Diagnostic Errors 1
- Discontinuities, Gaps, and Hand-Off Problems 1
- Medical Complications 1
- Medication Safety 12
Search results for "Press Release/Announcement"
- Press Release/Announcement
- Ambulatory Care
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 11, 2018.
National Alert Network. Horsham, PA: Institute for Safe Medication Practices; Bethesda, MD: American Society of Health-System Pharmacists. October 12, 2017.
Care devices that enable patients to administer medicines at home can have unintended consequences. This alert raises awareness of hazards related to insulin pen misuse and offers recommendations to reduce risks, such as training patients to properly use pen needles and engaging community pharmacists in verifying that patients understand appropriate administration techniques.
FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; July 30, 2015.
Look-alike and sound-alike drug names can contribute to confusion and result in medication errors. To raise awareness of potential wrong-patient errors due to similarity between two proprietary names, this announcement describes near misses with the drugs at the prescribing and dispensing stage and suggests clinicians use the generic names for the medications to reduce risk of patient harm.
FDA Safety Communication. Silver Spring, MD: US Food and Drug Administration; February 25, 2015.
The practice of using multi-dose insulin pens, meant for single patient use only, among multiple patients has been linked to health care–associated infections. This announcement outlines federal labeling requirements to raise awareness of the risks associated with this practice to prevent misuse of the devices.
AHRQ Announces Interest in Research About the Epidemiology of Patient Safety Risks and Harms in Ambulatory Health Care Settings.
Rockville, MD: Agency for Healthcare Research and Quality. Special Emphasis Notice. February 10, 2015. Publication No. NOT-HS-15-006.
This announcement highlights AHRQ funding opportunities to support continued research regarding effective tracking and identification of adverse incidents in ambulatory practice, with an emphasis on designing, refining, or validating epidemiological methods to augment the study of patient safety in ambulatory care.
Rockville, MD: US Food and Drug Administration; 2013.
To protect children and pets from accidental exposure to prescription medications, this consumer alert outlines the dangers of inappropriate storage and disposal of medication skin patches.
Warning! Severe burns and permanent scarring after glacial acetic acid (≥99.5%) mistakenly applied topically.
National Alert Network for Serious Medication Errors. Bethesda, MD: American Society of Health-System Pharmacists and Institute for Safe Medication Practices; January 23, 2013.
Describing several incidents of a corrosive chemical mistakenly applied to skin that led to severe burns and scarring, this alert recommends steps to prevent such errors.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; December 6, 2012.
Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; October 25, 2012.
This announcement raises awareness of risks associated with children accidentally ingesting over-the-counter eye drops and nasal sprays.
Institute for Safe Medication Practices and Institute for Safe Medication Practices Canada.
This tool evaluates the safety of cancer treatment delivery in hospitals and ambulatory care settings.
Rockville, MD: Agency for Healthcare Research and Quality; July 2011.
This announcement seeks participants in the AHRQ Patient Safety Culture Survey. Data collected will be hosted in a central repository for comparison with other similar organizations. The data submission process is now closed.
MedWatch Safety Alert. Rockville, MD: US Food and Drug Administration; February 17, 2010.
This announcement alerts consumers and health care professionals to dangers associated with name confusion on a widely used over-the-counter medicine.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; September 25, 2009.
This announcement explains the potential for medication errors due to a discrepancy between dosing instructions and dosing dispenser measurement units for the drug Tamiflu.
Washington, DC: National Quality Forum; September 2009.
This announcement provides background on the proposed 2010 effort to revise and expand the National Quality Forum list of never events.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; November 6, 2008.
This announcement recalls a mislabeled single-use, disposable syringe that could potentially cause dangerous insulin dosing errors.
Rockville, MD: Agency for Healthcare Research and Quality. Special Emphasis Notice. October 25, 2007. Publication No. NOT-HS-08-002.